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Abstract
Background: The epidemiological knowledge on acute condition of lymphatic filariasis is essential
to understand the burden and issues on management of the disease.
Methods: A one year long longitudinal prospective surveillance of acute adenolymphangitis (ADL)
was carried out in rural population of Orissa, India.
Results: The annual incidence of ADL per 1000 individuals is 85.0, and is slightly higher (P > 0.05)
in male (92.0) than in female (77.6). A steady rise in the incidence of ADL episodes along with the
age is recorded. The distribution indicates that persons with chronic disease are more prone to
ADL attacks. The average number of episodes per year is 1.57 (1.15 SD) per affected person, and
is gender dependent. Duration of the episode varies from 1 to 11 days with mean duration of 3.93
(1.94 SD) days. The chronic disease is the significant predictor for the duration of the episode. The
data show that fever and swelling at inguinal regions are most common symptoms.
Conclusion: The incidence, frequency and duration of ADL episodes in this community are similar
to that of other endemic areas. As the loss due to these ADL episodes is substantial, it should be
considered while further estimating the burden due to lymphatic filariasis. The disability and loss
caused by chronic forms of filariasis is higher, and the additional incapacity caused by the ADL
episode, majority of which occur among chronic filariasis patients, further poses the burden on
individuals and their families. Hence, morbidity management measures to prevent ADL episodes
among endemic communities are to be implemented.
Background
Lymphatic filariasis (LF) is associated with a wide range of
clinical signs, symptoms and sequelae, which are influ-
enced by a variety of factors related to host and parasite.
Acute episodes of adenolymphangitis (ADL) is one of the
symptoms and this acute clinical manifestation is charac-
terised by recurrent attacks of fever associated with
inflammation of the lymph nodes and or lymph vessels
[1]. The importance of acute clinical manifestations, i.e.
ADL, in natural progression of the disease, particularly the
development of chronic disease has been recognised by
filarialogists [2-4]. Though the need of systematic epide-
miological studies on acute LF or ADL is recognised, a few
studies have been undertaken in different endemic areas
[5-8]. The epidemiological information is useful to esti-
mate the burden of the disease and to develop morbidity
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management strategies. The present paper, based on a
longitudinal prospective fortnightly surveillance, reports
some epidemiological aspects of ADL episodes among
rural communities of Orissa, India, which is endemic for
LF caused by Wuchereria bancrofti.
Methods
Study area
This one year longitudinal prospective surveillance for
acute ADL episodes was carried out in two villages in
Khurda district of Orissa, India. These two villages are
close together by less than two kilometres and the geo-
graphical coordinates of these villages are 20° 11' N and
85° 40' E, and 20° 10' N and 85° 38' E. The study area is
known for its endemicity for LF caused by Wuchereria ban-
crofti, which is transmitted by Culex quinquefasciatus. The
microfilaria rate and density are 9.4% and 769 mf/ml
respectively [9]. The total disease and chronic disease rates
are 12.5% and 7% respectively [10]. The prevalence of
infection based on circulating filarial antigenaemia is
39.9% [11]. One round of mass drug administration of
diethylcarbamazine was given in the district in 1997 and
recorded around 30% of treatment compliance (BV Babu,
unpublished data). However, no data specific to these two
villages are available. The area is rural and its inhabitants
are mostly small farmers and daily wage labourers.
Data collection
A population of 1329 (685 males and 644 females) of two
villages were monitored for one year, during March 2000
– February 2001. Initially, the census of the villages was
conducted for demographic information and identities of
all individuals. The investigators visited all the house-
holds for every fortnight to detect individuals who were
suffering or had suffered from an acute attack during that
fortnight. In the present study, an acute ADL episode was
defined as the presence of local signs and symptoms such
as pain, tenderness, local swelling and warmth in the
groin, with or without associated constitutional symp-
toms such as fever, nausea and vomiting [12]. The investi-
gators, along with paramedical staff explained in the local
language the symptoms of acute episodes, which are com-
mon in this endemic population. As there are no other
diagnostic tools to identify ADL episodes, the present
method of symptomatic diagnosis was used. This method
of diagnosis through local terminologies was found to be
highly specific (specificity = 0.980) and sensitive (sensitiv-
ity = 0.978) for diagnosing ADL [5]. For individuals iden-
tified as affected with acute attacks during last fortnight,
the details including clinical symptoms, duration, etc.
were recorded, by recall method and in case of ongoing
episodes during visits, they were monitored. Majority of
these cases are examined during the episode by physicians
of local health institution. The available medical records/
prescriptions were used as adjunct. A few episodes are
clustered in members of the same household. The affected
individuals were tested for microfilaraemia. A finger-prick
thick blood film was prepared, using blood collected after
10 o'clock night, stained with Leishman's stain and entire
film was examined for microfilariae.
Data analysis
The data were analysed through SPSS V.8 for Windows.
The variation in incidence, frequency, number and dura-
tion of ADL episodes were assessed by employing the fol-
lowing statistical tests. Standardised normal Z-tests were
performed to assess the variation in the incidence between
different groups. Differences in number of episodes and
duration of episodes were assessed by t-tests and analysis
of variance (ANOVA). Multivariate ANOVA by regression
was used to examine the effect of gender, age and patho-
logical condition on the number and duration of episodes
in affected individuals. The seasonal variation in the fre-
quency of ADL episodes was assessed by χ 2 test.
Results
Incidence and distribution of acute episodes
Number of fortnightly rounds completed during one year
of study is 25 and 113 episodes were encountered among
72 patients in both villages. The annual incidence per
1000 population is 92.0 and 77.6 among men and
women respectively, and the overall incidence is 85.0 per
1000 population. The difference between male and
female is not significant (P > 0.05). However, the annual
incidence is significantly high (P < 0.001) among individ-
uals with chronic disease (957.0) than those without any
chronic manifestations (19.4). The age-wise incidence of
ADL episodes indicates a steady rise in the incidence of
Relation between annual incidence of ADL episodes and dif- ferent age groups among male, female and total population Figure 1
Relation between annual incidence of ADL episodes and dif-
ferent age groups among male, female and total population.BMC Public Health 2005, 5:50 http://www.biomedcentral.com/1471-2458/5/50
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episodes along with age among males and females, except
in the age group of 51–60 years (Fig. 1).
A total of 72 (52 males and 20 females) individuals of the
study population (5.42%) were affected with acute ADLs.
The age of the affected individuals varies from 7 years to
75 years with mean age of 36.23 ± 16.46 (SD) in case of
male and 45.30 ± 12.15 (SD) in case of female, with a sig-
nificant difference between two genders (P  < 0.05).
Among the total 72 patients suffered from acute episodes,
overt chronic symptoms were found among 53 patients
(73.61%). Out of total 113 episodes, 47 (41.59%) epi-
sodes are associated with lymphoedema, 38 (33.63%)
with hydrocele, 4 (3.54%) with both lymphoedema and
hydrocele and 24 episodes (21.24%) in individuals with-
out chronic manifestations (Table 1). The mean age of
patients with chronic manifestations (40.11 ± 15.22 SD)
is slightly higher than individuals without any chronic
manifestations (34.95 ± 17.68 SD), but the difference is
not significant (P > 0.05).
Frequency and duration of acute episodes
As 113 episodes were recorded among 72 patients, 20
(27.8%) patients experienced more than one episode.
Majority of patients (52; 72.2%) experienced acute epi-
sode only once in the year. It is followed by 12.5% of
patients with two episodes, 6.9% of patients with 3 epi-
sodes, 5.6% of patients with 4 episodes, and 1.4% of
patients each with 5 and 7 episodes per year. Among the
individuals with multiple episodes, majority (16 out of
20) are with chronic filarial symptoms (P < 0.001). The
average number of episodes per year is 1.57 (1.15 SD) per
affected individual. The multivariate ANOVA employed to
assess the influence of age, gender and pathology on
number of episodes per affected persons indicated that
only gender is identified as significant predictor to the
number of episodes per affected individual (P < 0.001)
(Table 1). Similar analysis is carried out to assess the effect
of age among hydrocele patients, and age and gender
among lymphoedema patients. These variables have no
impact on frequency of episodes among hydrocele and
lymphoedema patients (P > 0.05). There is significant var-
iation in the frequency of ADL episodes with seasons of
the year (P < 0.001). The average numbers of episodes per
month during summer (March to June), rainy season
(July to October) and winter (November to February) are
11.00, 10.75 and 6.50 respectively.
Duration of the episode varies from 1 day to 11 days and
the mean duration is 3.93 days (1.94 SD). In majority of
cases, the episodes persisted for 3 days (26.4%), followed
by 4 days (22.2%), 2 days (15.3%), 8 days (9.7%), 5 days
(8.3%), 1 day (5.6%), 6 days (5.6%), 7 days (5.6%) and
11 days (1.4%). When individuals' age, gender and
pathology were considered simultaneously in multivari-
ate ANOVA, the individuals' pathological condition
emerged as a significant predictor to the mean duration of
episode (P < 0.05) (Table 1). When the hydrocele and
Table 1: Association of gender, pathology group and age group with mean number of episodes and duration of episodes and details of 
multivariate ANOVA.
Independent 
Variable
Total number of 
patients 
in each category
Total number of 
episodes 
in each category
Mean number of episodes Mean duration (days) of episode
Mean ± SD Coefficient (P)a Mean ± SD Coefficient (P)b
Gender
Male 52 63 1.21 ± 0.57 1.169 (0.000) 3.95 ± 2.05 0.508 (0.221)
Female 20 50 2.50 ± 1.67 3.90 ± 1.79
Pathology group
Hydrocele 31 38 1.23 ± 0.67 0.276 (0.071) 4.56 ± 2.34 0.505 (0.034)
Lymphoedema 19 47 2.47 ± 1.71 3.74 ± 1.76
Both 3 4 1.33 ± 0.58 3.67 ± 1.15
None 19 24 1.26 ± 0.56 3.52 ± 1.62
Age group
7–20 years 10 16 1.60 ± 1.08 0.002 (0.768) 4.38 ± 1.82 0.023 (0.0557)
21–40 years 30 40 1.33 ± 0.84 4.24 ± 2.41
41–60 years 24 42 1.75 ± 1.45 3.60 ± 1.51
61–75 years 8 15 1.88 ± 1.25 3.64 ± 1.80
Total 72 113 1.57 ± 1.15 3.93 ± 1.94
aFor number of episodes: F = 9.317 (P < 0.001), Adjusted R2 = 0.260
bFor duration of episodes: F = 2.607 (P < 0.05), Adjusted R2 = 0.041BMC Public Health 2005, 5:50 http://www.biomedcentral.com/1471-2458/5/50
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lymphoedema patients are considered separately, age in
hydrocele patients and, age and gender in lymphoedema
patients have no significant impact on the duration of epi-
sode (P > 0.05).
Clinical symptoms associated with ADL episodes
Distribution of various clinical symptoms among these
acute cases is presented in Table 2. Occurrence of fever
(77.87%) and swelling of inguinal regions (63.72%) are
most common symptoms of acute cases. In the local lan-
guage, swelling of lymphatic nodes is known as Bagi or
Pichhuli, and is commonly perceived as the initial symp-
tom of LF among the study population. Pain and tender-
ness in different body parts are seen in majority of cases.
Presence of local swelling, anorexia, nausea and vomiting
are associated with ADL among majority of cases. It is
attempted to examine the differences in clinical presenta-
tion across gender and pathological groups. There are no
significant variations in occurrence of these symptoms
except in occurrence of pain and tenderness. Pain and ten-
derness in genitals is common in hydrocele patients, and
hence more frequent in male patients. In lymphoedema
patients, pain and tenderness are noticed in lower limbs.
No association was found between occurrence of these
symptoms and age groups. The microfilarae data indi-
cated that only 8, out of 72 acute patients (11.11%) are
microfilaraemic.
Discussion
To develop strategies for relieving and preventing the suf-
fering of filarial patients, it is essential to understand the
epidemiology of various forms of morbidity. The infor-
mation on acute form of LF, particularly on ADL is spo-
radic from a few endemic regions. The present
longitudinal prospective surveillance showed the annual
incidence of 85.03 of ADL episodes per 1000 population
in this rural Eastern Indian community. Similarly, a South
Indian rural community, which is endemic for bancroft-
ian filariasis recorded the annual incidence of 96.3 per
1000 population [6]. The incidence rates are available
from a few other endemic countries such as Ghana (96 per
1000 population) [5] and Tanzania (33 per 1000 popula-
tion) [8]. The proportion of people affected with ADL epi-
sodes in the present study (5.4%) is similar to that
reported from another bancroftian filarial endemic com-
munity from South India (5.3%) [6]. The age wise
distribution indicates that male recorded higher incidence
in all age groups except in the age groups of 41–50 years
and above 60 years of age. This age-wise incidence follows
the pattern with the prevalence of microfilaraemia and
chronic disease [13]. The variation could be due to differ-
ences in prevalence of chronic disease and differential sus-
ceptibility to ADL episodes for individuals with
lymphoedema and hydrocele. In the present population,
men recorded higher prevalence of chronic filarial disease
than women [10]. The mean age of affected individuals is
varying between male and female. The lower mean age of
male patients may be due to occurrence of hydrocele even
at lower age. In the present study population, majority of
affected individuals has only one episode per year and
only 27.8% of affected individuals have experience more
than once. The data showed that these multiple episodes
are more common in patients with chronic disease. The
mean number of episodes per year is significantly higher
among lymphoedema patients than even hydrocele
patients. A study from South India reported a direct rela-
tionship between the number of acute attacks and the
grade of lymphoedema [14]. It is also known that the fre-
quency of these attacks is generally higher in bancroftian
filariasis as compared to brugian filariasis [14,15]. Regard-
ing the seasonal variation in the frequency of ADL epi-
sodes, it is lower in winter than is summer and rainy
season. Some of the earlier studies reported higher fre-
quency in rainy season [16,17]. In Tanzania, the higher
incidence of ADL episodes during rainy season is related
to increased transmission by infective mosquito bites [8].
It is consistent with the hypothesis that ADL episodes may
be associated with allergic responses to massive parasite
antigen release [18,19]. There is uniformity in the associ-
ated symptoms of ADL episodes amongst various
endemic communities, though the etiology of the ADL is
not clear. The majority of the ADL patients in this study
are amicrofilaraemic, and this finding is in conformity
Table 2: Distribution of associated symptoms among the ADL 
cases.
Symptom Prevalence among 
episodes
Percentage
Pain in
Upper arms 12 10.62
Legs 83 73.45
Genitals 29 20.00
Breasts 1 0.88
Tenderness in
Upper arms 10 8.85
Legs 13 11.50
Genitals 24 21.24
Lymphangitis in
Left inguinal region 34 30.09
Right inguinal region 38 33.63
Left papillary 3 2.65
Right papillary 3 2.65
Swelling 92 81.42
Fever
High 61 53.98
Low 27 23.89
Anorexia 72 63.72
Nausea 61 53.98
Vomiting 32 28.32
Microfilaraemiae 13 11.50a
apercentage is to total number of patientsBMC Public Health 2005, 5:50 http://www.biomedcentral.com/1471-2458/5/50
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with earlier observations [5,19,20]. The limitation of this
study is that an insensitive method of microfilaria detec-
tion was used, i.e., finger prick method as opposed to
Nucleopore filtration method.
The incidence and duration of the ADL episode has
greater economic implication on individuals, their fami-
lies and community. There will be substantial loss of work
during these episodes and subsequent economic loss [21-
23]. In the present study population, on average each epi-
sode persists for 4 days, which is similar to the other
endemic areas [6,8,16,24,25]. The magnitude of loss due
to ADL episodes is substantial and it will be constituted as
a major proportion to the total burden of LF. While esti-
mating the global burden of LF, only the chronic forms of
disease were considered [26], perhaps due to lack of data
at that time. As the data on incidence and duration of ADL
episodes are available at least from some endemic areas,
they should be considered during further estimation of
disease burden due to LF. In the present study commu-
nity, it is reported that the chronic condition is posing
considering economic burden due to loss of work and
treatment costs [27]. It is well known that the disability
and economic loss caused by chronic filariasis is life long
and much higher. And additional incapacity caused by the
ADL episodes, majority of which occur in these chronic
filarial patients, further poses the burden on the individu-
als and their families. It is clear that there are two types of
ADL episodes, ADL secondary to bacterial or fungal infec-
tions and ADL caused directly by the parasite infection
itself [1]. For the episodes among chronic lymphoedema
cases, secondary bacterial infection may be plausible
explanation [28-30]. It is also evident from recent findings
that simple foot hygiene and prevention of secondary bac-
terial infection lower the incidence of ADL episodes
[28,31-33]. Shenoy et al. [34] demonstrated that well
designed programme of foot care significantly decreases
the frequency of ADL episodes. In this programme, metic-
ulous hygiene including use of foot wear, regular washing
of affected limbs, etc. to prevent injuries and infections
needs to be incorporated. Thus, it is essential to develop
and promote simple, cost-effective and user-friendly
measures to minimise the burden of acute disease of LF.
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